In the framework of the EU Initiative on Health Security, ECDC and the EU Member States set up an ‘Exchange of Experts’ programme aiming to provide experts from European Neighbourhood Policy (ENP) partner countries with opportunities to learn from the experiences of EU Member States within specific disease areas, and in turn, share their own experiences.
The information contained in this fact sheet is intended for the purpose of general information and should not be used as a substitute for the individual expertise and judgement of healthcare professionals.
ECDC and EMA have issued a joint statement on adapted COVID-19 vaccines and considerations for their use during the upcoming autumn 2023 vaccination campaigns.
See all information on COVID-19, situation updates, risk assessments, questions and answers, latest evidence, surveillance and laboratory guidance and how to protect yourself and others.
The mpox (monkeypox) virus is transmitted to humans through a bite or direct contact with an infected animal’s blood, body fluids or cutaneous/mucosal lesions.
COVID-19 vaccines aim to prevent COVID-19 by triggering an immune response. Safe and effective COVID-19 vaccines are a powerful tool for controlling the pandemic.